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During early embryogenesis, microglia arise from
yolk sac progenitors that populate the developing
central nervous system (CNS), but how the tissue-
resident macrophages are maintained throughout
the organism’s lifespan still remains unclear. Here,
we describe a system that allows specific, condi-
tional ablation of microglia in adult mice. We found
that the microglial compartment was reconstituted
within 1 week of depletion. Microglia repopulation
relied on CNS-resident cells, independent from
bone-marrow-derived precursors. During repopula-
tion, microglia formed clusters of highly proliferative
cells that migrated apart once steady state was
achieved. Proliferating microglia expressed high
amounts of the interleukin-1 receptor (IL-1R), and
treatment with an IL-1R antagonist during the
repopulation phase impaired microglia proliferation.
Hence, microglia have the potential for efficient
self-renewal without the contribution of peripheral
myeloid cells, and IL-1R signaling participates in
this restorative proliferation process.
INTRODUCTION
Microglia are central nervous system (CNS)-resident myeloid
cells that contribute to CNS development and maintain tissue
integrity in steady-state conditions (Davalos et al., 2005;
Nimmerjahn et al., 2005; Prinz and Priller, 2014). After in-
fection of the CNS, or other processes that involve tissue
damage, microglia play a critical role in clearing debris and92 Immunity 43, 92–106, July 21, 2015 ª2015 Elsevier Inc.restoring the CNS steady state (Koizumi et al., 2007; Sierra
et al., 2010).
Developmental studies show that microglia arise on embry-
onic day 8.5 from early yolk-sac-derived precursors (Ginhoux
et al., 2010) that have erythro-myeloid potential. Genesis of
microglia depends on the transcription factors PU.1 and IRF8
(Kierdorf et al., 2013) but is independent of Myb (Schulz et al.,
2012). Once microglia cells migrate to the neuroectoderm, they
proliferate to fill up their compartment, whose generation de-
pends on macrophage colony-stimulating factor (CSF-1)-recep-
tor engagement by CSF-1 or its analog IL-34, which are both
differentially expressed in specific CNS regions (Greter et al.,
2012; Wang et al., 2012).
Along with most other tissue macrophage populations, micro-
glia are established during prenatal development (Alliot et al.,
1999; Ginhoux et al., 2010; Hashimoto et al., 2013; Schulz
et al., 2012; Yona et al., 2013). This finding challenged the clas-
sical theory of the mononuclear phagocytes system. Assuming
that tissue macrophages derive from monocytes at postnatal
stages and that they share a common bonemarrow (BM) precur-
sor, these cells should be grouped together (van Furth et al.,
1972). Early studies involving BM chimeras established that
BM stem cells have the ability to populate the entire CNS and
differentiate into parenchymal microglia-like cells (Brazelton
et al., 2000; Eglitis and Mezey, 1997; Priller et al., 2001). How-
ever, whole-body irradiation harms the blood brain barrier
(BBB), and entry of BM-derived cells represent an experimental
artifact that cannot be generalized (Mildner et al., 2009). In line
with this, Ajami et al. (2007) demonstrate that combining parabi-
osis and myelo-ablation under conditions that avoid irradiation
fail to produce lasting contributions of BM-derived cells to the
microglia pool. Moreover, even in the context of inflammation,
when monocytes contribute to the inflammatory milieu (Mildner
et al., 2007), they do not join the long-term resident microglia
pool (Ajami et al., 2011). Instead, the microglia compartment
seemed to recover without external input. Proliferative potential
of terminally differentiated macrophages is also shown for lung
and BMmacrophages, which display local self-renewing capac-
ity after depletion without input from definitive hematopoiesis
(Hashimoto et al., 2013).
Using a microglia depletion model that is based on expression
of a herpes simplex virus thymidine kinase (HSVTK) transgene
under a CD11b promoter, it is shown that BM-derived cells
can replace depleted microglia and give rise to a long-lasting
macrophage compartment (Heppner et al., 2005; Grathwohl
et al., 2009). However, this model involves whole-body irradia-
tion, which impairs BBB integrity and thus affects peripheral
cell entry to the brain (Mildner et al., 2007). The true potential
of the endogenous yolk-sac-derived microglia to recover from
depletion, and whether these cells can be replaced by BM-
derived cells or circulating monocytes, remains an ongoing
debate.
In this study, we made use of a new Cx3cr1CreER-based sys-
tem (Goldmann et al., 2013; Yona et al., 2013) allowing the
conditional depletion of microglial cells while avoiding the gen-
eration of BM chimeras. We found that, in contrast to previous
reports, microglial cells repopulating the CNS arose exclusively
from an internal CNS-resident pool. Only when mice were
irradiated and additionally received a BM transfer were re-
populating cells of BM origin. The microglia that originated
from internal pools expressed the IL-1 receptor, but brain
macrophages arising from the BM did not. Moreover, treatment
with IL-1 receptor antagonist delayed the microglial self-
renewal process. Taken together, we established that the
microglia compartment was able to efficiently renew itself inde-
pendently from BM precursor cells and that IL-1 signaling was
involved in this self-renewal process.
RESULTS
Microglia Are Efficiently Depleted via the
Cx3cr1CreER:iDTR System
Microglia originate from yolk-sac-derived precursors and seed
the developing brain during embryogenesis (Ginhoux et al.,
2010; Kierdorf et al., 2013). Although this developmental aspect
of microglia is understood, controversy still remains as to what
extent and from what sources microglia are maintained and re-
plenished in the postnatal steady state. Homeostatic turnover
rates of microglia are rather low (Lawson et al., 1992), but
some studies suggest that under pathological conditions new
microglia can arise from BM-derived precursors (Varvel et al.,
2012). Because of the specific experimental conditions involved,
the interpretation of these findings, however, remains controver-
sial (Ajami et al., 2011; Mildner et al., 2007). To better understand
the origin of microglia and their self-renewal potential, we used a
new mouse line, in which a tamoxifen (TAM)-inducible Cre-re-
combinase is expressed under the control of the Cx3cr1 pro-
moter (Cx3cr1CreER mice) (Yona et al., 2013). When activated
by TAM, nuclear translocation of the CreER fusion protein is tran-
sient and recombination occurs only for a limited time period. If
cells are analyzed at a later time point, only long-lived cells
(e.g., microglia) will still carry Cre-mediated mutations, whereas
short-lived cells (e.g., monocytes) will be replaced by non-
mutated progenitors (Goldmann et al., 2013). To test the system,Cx3cr1CreER mice were crossed to the YFP reporter strain (Srini-
vas et al., 2001) and injected twice with TAM at the age of
2 weeks, as shown in Figure S1A. After this treatment, almost
all microglial cells expressed eYFP, whereas monocytes and
macrophages did not (Figure S1B). For specific microglia abla-
tion, we crossed Cx3cr1CreER mice to iDTR mice (Buch et al.,
2005), generating DTRMG mice. Cre-mediated recombination
was induced in DTRMG mice by TAM injections of 2-week-old
mice, leading to surface expression of the diphtheria toxin recep-
tor (DTR) by microglia. For cell depletion, DTRMG mice were
treated with diphtheria toxin (DT) at 8 weeks of age, resulting in
80% depletion of microglia 3 days after DT injection, as quanti-
fied by flow cytometry (Figures 1B and 1C). Similar results
were obtained in quantitative RT-PCR for the macrophage
marker CD11b (Figure 1E) and quantification of Iba1+ cells in his-
tology (Figure 1F).
Microglia Ablation Is Followed by Rapid Repopulation
To complete the evaluation of our microglia ablation scheme, we
extended the analysis to days 3, 7, and 14 after the first DT injec-
tion (Figures 1A and 1B). Quantitative analysis of total cell counts
from the microglia gate (CD45intCD11bhi) confirmed a depletion
rate of 80% at day 3, when compared to TAM- and DT-treated
control mice (Figures 1C and S2A). At day 7 after DT application,
we noted that a large number of CD11b+ cells in the CNS were
CD45hi, identifying either activatedmicroglia or infiltrating mono-
cytes. However, from day 7 onward, the total cell number of
CD11b+ cells was very similar to that seen in controls. At day
14 after DT injection, the numbers of microglia and CD11b+ cells,
as well as their CD45 expression, were restored (Figures 1B–1D
and S2A). CD11b mRNA expression measured in whole cortex
homogenates mirrored the flow cytometry results, with a strong
reduction on day 3 and restored levels from day 7 after DT on-
ward (Figure 1E). As seen in Figure 1F, we detected very few mi-
croglia in cortex, cerebellum, and spinal cord ofmice 3 days after
DT application. The few surviving Iba1+ cells did not show the
typical ramified phenotype of steady-state microglia, but instead
displayed a more compact morphology with fewer and shorter
extensions (see inserts in Figure 1F). In addition, flow cytometry
and histology on days 3 and 7 after DT injection also revealed
higher expression of MHC class II and CD86, indicative of activa-
tion of remaining microglia (Figures S1C–S1E). These findings
establish that microglia ablation is followed by a robust repopu-
lation that starts before day 7 and is completed by day 14
(Figure 1F).
BM-Derived Macrophages Contribute to the Microglia
Pool in BM Chimeric Mice
To determine whether the repopulating brain macrophages
originated from a CNS-resident, internal pool or from a periph-
eral source, we employed the DTRMG mice in a BM chimeric
system. Lethally irradiated DTRMG mice that had undergone
TAM-induced Cre recombination (Figure 2A) were reconstituted
with BM of eYFP reporter animals (Srinivas et al., 2001). In the
resulting mice, the radio-resistant host microglia can be ablated
by DT application and BM-derived peripheral cells are detect-
able by YFP expression. Interestingly, after DT treatment of
the BM chimeras, all cells in the microglia gate (Figure 2B) ex-
pressed YFP. Notably, an intravenously engrafted BM cellImmunity 43, 92–106, July 21, 2015 ª2015 Elsevier Inc. 93
Figure 1. Efficient Ablation of Microglia Is Followed by a Fast Repopulation within 4 Days
(A) Representative FACS plots of the brain (top) and spinal cord (bottom) are depicted for time course depletion. Dead cells were excluded with a live cell marker
and debris by size.
(B) The bar graphs depict total cell counts (±SEM) within the CD45intCD11bhi microglia gate (left) and total CD11b+ cells (right). n = 3. Control, black bars; d3, blue
bars; d7, red bars; and d14, white bars.
(C) A histogram overlay of the mean fluorescence intensity (MFI) of CD45 expression for all time points.
(D) mRNA was purified from cortex homogenate and the expression of Cd11b (±SEM) was quantified by real-time PCR relative to the expression of hprt.
(E) Histological analysis with Iba1-specific antibodies. An example of each time point is shown for cortex, cerebellum, and spinal cord (left). Scale bars represent
20 mm. The bar graphs represent the percent of Iba1+ cells (±SEM) per mm2 for each region on each time point (right).
See Figure S2. Statistical significance (unpaired Student’s t test) is indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.
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Figure 2. In a BM Chimera Model, Microglia Are Replaced by BM-Derived Macrophages Regardless of a-CCR2 Treatment
(A) The time scale indicates the required injections for BM reconstitution, microglia depletion, and a-CCR2 treatment.
(B) Brain homogenates fromDTRMG and control mice at day 7 after depletion and treated with a-CCR2 or with isotype control antibodies were analyzed by FACS.
Representative FACS plots for CD11b and CD45 are shown.
(C) The bar graphs of total event counts (±SEM) summarize all FACS results. a-CCR2-treated mice are represented in blue, littermate controls in black, isotype-
treated animals in red, and isotype-treated controls in gray bars.
(D) Representative histograms showing eYFP expression for the different groups described in (B).
(E) Total event counts of eYFP+ cells (±SEM) are summarized according to (C).
(F) Analog to (B) the expression of CD45 MFI is shown in a histogram overlay (left). All MFIs (±SEM) are summarized in bar graphs (right).
(G) DTRMG mice and controls were reconstituted with eYFP+ BM. After microglia depletion, mice were allowed to recover for 12 weeks and brains analyzed by
FACS. Cells were pre-gated as CD11bhiCD45int. One representative plot displaying eYFP expression is shown.
(H and I) Brain sections are shown for controls, DTRMG d7, and DTRMG 12w, stained with antibodies specific to eYFP (H) or Iba1 (I). Two magnifications of the
cortex are shown. Scale bars represent 200 mm (top) and 100 mm (bottom).
See Figure S3. All statistical significances (unpaired Student’s t test) are indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.
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suspension can seed the brain with early hematopoietic pre-
cursors without the involvement of a monocyte intermediate
(Ajami et al., 2011). We therefore also specifically assessed
contributions of monocytes by treating one group of animals
with a-CCR2 antibodies (MC-21). This regimen depletes circu-
lating Ly6C+ monocytes and thus prevents their entry into the
brain (Mildner et al., 2009). Although the a-CCR2 treatment
was effective in itself and Ly6Chi blood monocytes were effi-
ciently ablated (Figure S2C), the depleted microglia in the
CNS were still replaced by BM YFP+ cells (Figures S2D and
2E). Regardless of whether the mice were treated with the
a-CCR2 regimen, the majority of brain macrophages expressed
YFP (Figures 2D and 2E) and was therefore derived from pe-
ripheral BM progenitors. We found that the repopulating mac-
rophages in BM chimeras had upregulated CD45 in a similar
fashion as the microglia in the non-chimeric system (Figure 2F).
At 12 weeks after ablation, when the brain was fully repopu-
lated, most brain macrophages remained YFP+, suggesting
that these cells populate the CNS permanently and potentially
also functionally replace the microglia (Figure 2G). Finally, we
analyzed the distribution of these BM-derived brain macro-
phages. As can be seen in Figure 2H, few YFP+ cells were
detected in control chimeras, potentially as an artifact of irradi-
ation and BM transfer (Figure 2H; Mildner et al., 2007). When
analyzing the cortex by Iba1 staining (Figure 2I), we found a
normal distribution of microglia in DT-treated, non-DTR trans-
genic control chimeras, whereas DT-treated DTRMG mice
showed less process-forming brain macrophages at day 7. In
contrast, the CNS of DTRMG mice largely resembled WT
CNS in terms of distribution and morphology of Iba1+ cells at
12 weeks after depletion. Iba1 staining does not discriminate
between microglia and BM-derived brain macrophages. How-
ever, similar data were obtained when the sections were
analyzed for eYFP expression (Figure 2H). Other brain regions,
such as the cerebellum and brain stem, showed similar recon-
stitution kinetics (Figures S2D and S2E).
In the Absence of Irradiation, Microglia Renew
Exclusively from Internal Pools
To circumvent the inherent experimental pitfalls associated with
BM chimeras (Lampron et al., 2012), we next crossed the
DTRMG mice to Rosa26-STOP-eYFP reporter mice (Srinivas
et al., 2001), resulting in animals that harbor, after TAM injec-
tion, microglia that express both eYFP and DTR (Figure 3A).
The proportion and absolute number of eYFP-expressing cells
decreased by 80% on day 3 and increased again on day 7 (Fig-
ures 3B and 3C). These findings suggest that microglia were re-
populated from cells that were CX3CR1
+ at the time of TAM
treatment, most likely microglia that originated from a CNS-
resident internal pool. In addition, both eYFP+ and eYFP mi-
croglia numbers increased by day 7 (Figure 3D), suggesting
that microglia that had escaped Cre-mediated recombination
contributed in a similar manner to microglia repopulation. His-
tological analysis for eYFP and Iba1 expression corroborated
the flow cytometry data. As shown for the cortex in Figure 3E,
we detected only a few eYFP+ and Iba1+ microglia at day 3 af-
ter ablation, whereas by day 7, the cell number as well as the
morphologic appearance of these cells reached levels similar
to the control animals.96 Immunity 43, 92–106, July 21, 2015 ª2015 Elsevier Inc.Microglia Ablation Leads to a Cytokine Storm and
Astrogliosis
We reasoned that the massive microglia cell death in this genetic
model is likely to provoke changes in the CNS environment.
Indeed, we detected increased mRNA expression of pro-inflam-
matory cytokines (such as TNF-a and IL-1b), chemokines (such
as CXCL9 and 10 and CCL2, 5, and 7), and costimulatory mole-
cules in the cortex of microglia-depleted animals at all the indi-
cated time points (Figure S3A). Interestingly, qPCR analysis
revealed increased levels of the astrocyte marker GFAP. (Fig-
ure S3D), and also immunofluorescence staining showed higher
amounts of GFAP protein, particularly in the cortex and brain
stem (Figure S3B) that were due to a pronounced accumulation
of GFAP+ cells (Figure S3C). Collectively, these findings estab-
lish that other CNS-resident cells, in particular astrocytes, react
to the ablation-induced environmental changes inside the CNS.
Clusters of Proliferating Microglia Repopulate the CNS
While analyzing the microglia distribution, we noticed that, at
the peak of repopulation at around day 7, many microglial cells
were found in micro-clusters, defined as formations of five or
more cells within an area of 0.6 mm2 (Figure 4A, indicated by
arrowheads). The clusters presented in all CNS regions,
including cortex, cerebellum, brain stem, and dentate gyrus (Fig-
ure 4A). Clusters were first observed on day 7 after depletion but
were mostly resolved by day 14 (Figure 4B). Based on these ob-
servations, we investigated whether the repopulating microglia
originated from cells escaping ablation and underwent massive
proliferation. To follow cell proliferation, mice were fed with
BrdU starting 2 days prior to depletion until analysis at day 7.
When brain slices were stained for BrdU and Iba1, we observed
proliferating microglia as early as day 3 after DT injection (Fig-
ure 4A). At day 7, these cells formed clusters of multiple cells
that were BrdUhi (Figure 4C). In the same figure, there are single
BrdU+ cells that seem to have migrated away from the cluster,
suggesting that repopulation of the surrounding tissue originates
from there (Figure 4C, cortex; Movie S1). Finally, on day 14,
BrdU+ microglia were still detectable in high numbers, although
at this late time point the cells were widely distributed in the
tissue and no longer organized in clusters (Figure S4). By co-
staining for BrdU and YFP, wewere able to verify that these clus-
ters consisted exclusively of CNS-resident cells and that the
eYFP+microglia population was the major source of proliferating
cells after DT-mediated ablation (Figure S4B). These data sug-
gest that after the ablation of the vast majority of microglia, the
remaining cells rapidly proliferate in order to repopulate micro-
glia-depleted areas.
CNS-Derived Microglia Display Unaltered Gene
Expression Profiles, whereas BM-DerivedMacrophages
Are Distinct
Next, we aimed to characterize the gene expression profile of the
newly formed microglia and to compare it with the signature of
BM-derived macrophages that repopulate the microglia niche
in the BM chimeras. To that end, we sorted eYFP+ repopulating
brain macrophages from either BM chimeric mice (as described
in Figure 2 [BM origin]) or non-irradiated mice (described in Fig-
ure 3 [CNS origin]). For comparison, we isolated microglia from
control animals based on their expression of CD45int and
Figure 3. Microglia Renew from Internal Pools without the Contribution of Peripheral Circulating Cells
(A) DTRMG mice crossed to R26-YFPfl/fl mice to obtain mice that express the DTR and eYFP.
(B) Representative FACS histograms for eYFP expression of CNS homogenates pre-gated on microglia (control, black; d3, blue; d7, red). The right panel shows
an overlay of all three histograms at the different time points and illustrates the distribution and relation of total cell numbers.
(C) Statistical analysis of total cell number of eYFP+ microglia (±SEM) represents the average of total cell counts (control, n = 3; d3, n = 4; d7, n = 4).
(D) The comparison between eYFP+ and eYFP cells clarifies the distribution between the two populations.
(E) The distribution of total cells was confirmed with immunohistochemical staining for eYFP and Iba1. Microglia cell numbers (±SEM) in the cortex of control, d3,
and d7 animals were quantitated. Scale bars represent 100 mm. The cell counts were normalized to the controls and the values are expressed in the bar graphs.
Statistical significance (unpaired Student’s t test) is indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.CD11bhi. Isolated mRNA from these three microglia populations
was subjected to RNA sequencing (Figures 5A–5C and 5E).
Comparison of the expression profiles of the three brain macro-
phage populations revealed higher numbers of differentially ex-pressed genes in BM-derived macrophages versus either con-
trol or newly generated microglia. In contrast, there were fewer
differences between CNS-derived repopulating and control mi-
croglia (Figure S5A). Heat map analysis of all differentiallyImmunity 43, 92–106, July 21, 2015 ª2015 Elsevier Inc. 97
(legend on next page)
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expressed genes, constructed on the basis of hierarchical clus-
tering of gene expression values, displayed a close relationship
across the samples within one biological group. More impor-
tantly, the gene expression pattern of control microglia resem-
bled very closely that of CNS-derived repopulating microglia,
but differed substantially from the expression pattern found in
BM-derived brain macrophages (Figure 5A). To examine these
differences, we plotted the relationship between the three
groups by principal-component analysis (PCA). The samples
within each biological group clustered together, confirming
reproducibility of the results. In the PCA analysis, the distance
of control microglia to BM-derived macrophages was greater
than tomicroglia originating fromCNS-internal pools (Figure 5B).
Similar results were obtained, when we analyzed the transcrip-
tome data focusing on the genes included in the MG400 chip,
which comprises genes characteristic for microglia and macro-
phages (Butovsky et al., 2014). Heat map analysis of this gene
set confirmed the close relation between control and CNS-
derived repopulating microglia (data not shown). Butovsky and
colleagues also described 89 genes that are microglia specific.
87 of these genes were found in our analysis and the great ma-
jority was differentially expressed (Figure S5C) and upregulated
in control and CNS-derived microglia, when compared to brain
macrophages of BM origin. The signature genes P2yr12, Mertk,
Pros1, C1qa, Olfml3, Entpd1, Hexb, and Tmem119 were also
validated by qPCR (Figures 5E, 5F, and S5B). BM-derived mac-
rophages isolated at day 28 still showed differences compared
to the controls in the expression profile of themicroglia signature
genes (Figure 5F). Notably, the growth factor Csf-1 and its recep-
tor displayed their highest expression in the CNS-derived micro-
glia (Figures 5C and 5D) andwere not upregulated in BM-derived
macrophages isolated on day 7 or day 28 after depletion.
Nestin Is Expressed in Repopulating CNS-Derived
Microglia and BM Macrophages
It has been shown recently that during repopulation, microglia
start to express the neuronal stem cell marker Nestin (Elmore
et al., 2014). We confirmed these findings by performing Nestin
and Iba1 immuno-histological co-staining, demonstrating that
microglia transiently express nestin. In controls and animals on
day 3 after ablation, nestin expression was visible in the hippo-
campus but absent from microglia. On day 7 after ablation, a
strong Iba1/Nestin coexpression was visible, particularly in the
clusters of proliferating microglia, but by day 14, nestin was no
longer expressed by microglia (Figure S5E). The BM macro-
phages in the CNS also showed strong Nestin expression.
Detectable amounts of nestin RNA were also found in the
RNA-seq data and qPCR, where it is expressed at even higher
levels in the BM macrophages compared with CNS-derived mi-
croglia (Figure S5D). These data establish that nestin can be ex-Figure 4. Microglia Form Proliferating Clusters to Reconstitute CNS
(A) Representative pictures of immunohistochemistry for eYFP (top) and Iba1 (bo
highlight a cluster formation (R5 cells).
(B) The total number of clusters per region (±SEM) is represented by the bar gra
(C) Mice were fed with 0.6 mg/ml BrdU in drinking water throughout the depletion
of BrdU (green) and Iba1 (red) stained sections are shown.
Scale bars represent 10 mm in (A)–(C) and 50 mm in (D)–(L). See Figure S4. Statisti
and ***p < 0.001.pressed by both CNS-derived and BM-derived macrophages.
Taken together, the analyzed gene expression profiles clearly re-
vealed differences between CNS-derived microglia and BM
macrophages repopulating the brain.
Interleukin-1 Signaling Is Involved in Microglia
Repopulation
The NGS data and their qPCR validation highlighted two genes,
il1r1 and il1a, which displayed higher expression in the CNS-
derived, repopulating microglia, compared to control microglia
and to BM-derived brain macrophages (Figures 6A and 6B).
Immunohistochemistry also revealed a high expression of IL-
1R1, particularly in the proliferative clusters (Figure 6C). Because
IL-1 has been found to induce cell proliferation and activation
(Basu et al., 2002; Pineau and Lacroix, 2007; Pineau et al.,
2010), we further investigated the role of IL-1 signaling in the mi-
croglia repopulation. To that end, we superimposed our ablation
protocol with IL-1 neutralization. We injected DT-treated DTRMG
mice with soluble IL-1 receptor antagonist (IL-1Ra, Anakinra)
intra-cerebroventricularly (i.c.v.) twice on days 3 and 4 after
depletion and analyzed the mice on day 7. The i.c.v. injections
of IL-1Ra into the third ventricle delayed the repopulation of mi-
croglia in the cortex, cerebellum, and thalamus (Figure 6D). The
brain stem showed no differences in repopulation, possibly due
to inefficient distribution of IL-1Ra when injected i.c.v. into the
third ventricle (Chauhan et al., 2001). In addition, themorphology
of the repopulating cells changed dramatically after IL-1Ra injec-
tions. Specifically, cells did not acquire the typical microglia
morphology, i.e., ramification, but remained round in shape
and lacked an abundance of processes. Astrocytes did not
show any differences in GFAP expression across the brain re-
gions in the different samples (Figures 6D and S7A). Additionally,
the number of Olig2+ cells remained stable and therefore re-
vealed no influence of IL-1Ra on oligodendrocyte precursors
and mature oligodendrocytes (Figures S7A and S7B).
IL-1Ra Blockade Affects Microglia Proliferation Early
after i.c.v. Treatment
Similarly to our previous experiments, we i.c.v. injected DTRMG
mice twice with IL-1Ra on day 3 and day 4 after depletion, fed
them with BrdU, and then analyzed them on day 5. The absence
of TUNEL-positive cells in the samples suggested that IL-1Ra
treatment did not provoke apoptosis of microglia (data not
shown). In all the examined brain regions (cortex, cerebellum,
thalamus, and brain stem), we found reduced numbers of
Iba1+ cells in the IL-1Ra-treated mice after microglia depletion
compared with PBS-treated controls (Figures S6A and S6B).
Analysis of proliferation of repopulating microglia revealed
essential differences in BrdU expression across the samples
(Figure 6A). As expected, microglia in the controls treated withttom) for the given brain regions. Scale bars represent 50 mm. The arrowheads
phs. One cluster consists ofR5 microglia cells.
time course. Single staining and a merge of fluorescence microscopic pictures
cal significance (unpaired Student’s t test) is indicated as *p < 0.05, **p < 0.01,
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Figure 5. CNS-Derived Microglia Retain Microglia Gene Expression in Contrast to BM-Derived Macrophages
(A) Heat map of all DE genes in FACS-sorted microglia populations. Each row represents one specific gene; the columns represent different samples. The values
shown are normalized and standardized by row to show variations across the samples (blue, downregulation; red, upregulation). The dendrogram above the heat
map shows the relationship between the different samples based on similar expression levels across the three conditions. The dendrogram on the left is con-
structed on the basis of hierarchical clustering of the DE gene expression.
(B) The distances between the populations, based on two principal components for the top 1,000 DE genes, are shown in the principal component analysis (PCA)
plot. The distance between CNS-derived samples and WT microglia is significantly (p % 0.05) smaller than the distance between BM-originated and WT.
Significances are calculated by permutation test.
(legend continued on next page)
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IL-1Ra did not incorporate BrdU. In line with previous experi-
ments (Figure 4C), the depleted and PBS-treated mice showed
BrdU incorporation in Iba1+ cells. After depletion and IL-1Ra
treatment, themicroglia did not test positive for BrdU (Figure 6A),
indicating that IL-1Ra treatment hindered proliferation of
microglia during depletion. Similar results were obtained by his-
tology, using antibodies specific for Ki67. IL-1Ra-treated animals
displayed fewer CD11b+Ki67+ cells than controls (data not
shown).
Conditional Ablation of IL-1R1 on Microglia Affects
Microglia Maintenance
IL-1R1 was previously thought to exert all actions of IL-1, and
for decades the field of inflammation has used Il1r1/ mice
originally generated by targeting deletion of exon 1 and 2
(Glaccumetal., 1997;Labowetal., 1997).However, a recent study
found that an alternative promoter upstreamof exon 3 leads to the
expression of a truncated signaling receptor named IL-1R3 (Qian
et al., 2012), which is thought to account for IL-1R1-independent
IL-1 actions that we have previously identified in glial cells (Andre
et al., 2006). We have therefore generated a new mouse line
(Il1r1fl/fl) in which exon 5 is flanked with LoxP sites, thus allowing
deletion of the three known IL-1 receptor isoforms. We crossed
the mice carrying Il1r1fl/fl allele to the Cx3cr1CreER mice and
induced in the resulting mice, termed IL-1R1MG, the deletion of
IL-1R1 specifically in microglia by injection of TAM according to
the previously described protocol for DTR induction. Microglia of
the IL-1R1MGmice show abnormal distribution (Figure 7A), result-
ing in reduced Iba1+ cell numbers (Figure 7B) in cortex, brain stem,
thalamus, and cerebellum. Furthermore, IL-1R1-deficient micro-
glia displayed atypical morphology as demonstrated in three-
dimensional reconstructions of confocal z-stacks. Specifically,
IL-1R1-deficient microglia had more processes, which appear
thicker and more branched (Figure 7C and Movies S2, S3, S4,
and S5). Taken together, our results demonstrate that the condi-
tional deletion of the IL-1R1 seemed to disturb microglia mainte-
nance in the steady state.
DISCUSSION
Microglia are CNS-resident tissue macrophages that arise from
early yolk sac progenitors (Ginhoux et al., 2010; Kierdorf et al.,
2013) and exhibit self-renewing potential, comparable to other
macrophages found in spleen, liver, or pancreas (Schulz et al.,
2012). Similarly, lung, peritoneal, and BM macrophages are
maintained locally, without the contribution of circulating mono-
cytes, under steady-state condition (Hashimoto et al., 2013;
Yona et al., 2013). In contrast, intestinal CX3CR1
+ macrophages,
situated in an organ characterized by ongoing mild inflammation
due to luminal microflora and its products, are constantly replen-
ished by Ly6Chi blood monocytes (Varol et al., 2009). It has been
shown previously that during CNS inflammation, monocyte
recruitment to the brain occurs only transiently and does not(C) Expression values (±SEM) of Csf1r and Csf1 obtained from NGS analysis.
(D) qPCR validation of Csf1r and Csf1 expression (±SEM).
(E) Expression values (±SEM) of the MG signature genes P2yr12, Mertk, Pros1, a
(F) qPCR validation of expression (±SEM) of the microglia signature genes.
Statistical significance (unpaired Student’s t test) is indicated as *p < 0.05, **p <persistently contribute to the microglia pool (Ajami et al., 2007;
Jenkins et al., 2011).
Recently, Cx3cr1CreER mice have been presented as a novel
tool that allows for the targeting of microglia in a cell-type-spe-
cific and inducible fashion (Yona et al., 2013; Goldmann et al.,
2013).Wemade use of this systemhere to express a toxin recep-
tor specifically on microglia (DTRMG mice), allowing us to ablate
these cells by systemic administration of DT. We demonstrated
that after ablation, the microglia compartment could be rapidly
replenished, either from an intrinsic pool, or, in the case of BM
chimeras, by BM-derived cells. Nonetheless, the two resulting
brain macrophage populations differed and at the time points
analyzed onlymicroglia-derived cells adopted a propermicroglia
RNA expression profile.
In steady state, microglia are quiescent with very little turnover
(Lawson et al., 1992), but when required, these cells can exert
massive proliferation, reminiscent of their expansion when they
seed the brain during embryonic development (Ginhoux et al.,
2010) or during CNS inflammation (Go´mez-Nicola et al., 2013).
In our repopulation model, we observed a large number of clus-
ters of dividing microglia that appeared shortly after ablation and
disappeared once the microglia compartment had been replen-
ished. The trigger for microglia proliferation is most likely the
sensing of the empty niche potentially mediated by a change
of IL-34 and Csf-1 levels or by the massive cell death that occurs
after ablation. It is feasible that the same mechanism applies for
the brain in steady state too, but at a much slower rate that is
difficult to observe. In our depletion system, the clusters of prolif-
erating microglia were observed after ablation, exclusively in
non-irradiated mice (CNS-derived cells). At none of the time
points analyzed were the clusters of proliferating microglia found
after depletion in the BM-chimeric system (peripheral progeni-
tors). This could be related to a direct effect of irradiation that
impairs proliferation capacity to the CNS-resident microglia.
However, we demonstrated that without irradiation, microglia
are repopulated from a highly proliferative CNS internal pool. It
could be that microglia are replenished from as yet undefined
CNS-resident progenitors. Because our reporter fate map
approach shows that microglia arise from CX3CR1
+ cells, we
favor the scenario that newly generated cells derive from residual
non-depleted microglia. This would be in line with recent studies
that demonstrate that terminally differentiated macrophages
retain the potential to expand (Sieweke and Allen, 2013; Wynn
et al., 2013).
Our data show that in the BM chimeric system, microglia are
replaced by peripheral progenitors that have most likely entered
the unprotected CNS as an artifact of irradiation, at the time of
the BM engraftment. It should be mentioned that due to irradia-
tion, at least three elements contribute to BMT-associated
artifact: damage to the BBB, flooding of the circulation with he-
matopoietic stem cells, and irradiation-induced abrogation of
proliferative potential of resident cells in the CNS. Corroborating
earlier findings (Ajami et al., 2011; Mildner et al., 2007), ournd C1qa (according to Butovsky et al., 2014).
0.01, and ***p < 0.001. See Figure S5.
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Figure 7. ConditionalDeletionof IL-1R1 inMi-
croglia Results in Lower Microglia Numbers
and Microglia Morphological Changes
(A) IL-1R1MG mice show a different abundance of
microglia throughout the tissue compared to control
animals seen in cortex, brain stem, thalamus, and
cerebellum of 3-month-old mice. Scale bars repre-
sent 200 mm.
(B) Quantification of the total cell numbers (±SEM).
Ten fields per slice and two to three slices per animal
were counted on a 203 magnification. Statistical
significance (unpairedStudent’s t test) is indicatedas
*p < 0.05, **p < 0.01, and ***p < 0.001.
(C) For comparison of IL-1R1MG to control animals, a
3D reconstruction of single Iba1+ cells taken from
each brain region are shown. Scale bars represent
20 mm.results with the a-CCR2 treatment establish that the BM progen-
itors that repopulate the microglia are not monocytes.
A new microglia progenitor was recently characterized by
Nestin expression (Elmore et al., 2014). Interestingly, we found
that our CNS-derived (eYFP+) microglia also expressed Nestin
protein from day 7 onward, with the highest expression levels
in the clusters. This was, importantly, not an exclusive marker
for microglia, because the BM macrophages detected in the
CNS of BMT mice also expressed Nestin. These results suggest
that nestin expression is triggered on myeloid cells, irrespective
of their origin, by the CNS environment.
Global transcriptome analysis revealed that repopulated mi-
croglia, derived from CNS-intrinsic cells, have a similar gene
expression pattern as WT microglia, whereas the BM-derived
brain macrophages display a distinct gene expression profile
even 28 days after depletion. These findings substantiate earlier
observations that reported differential gene expression patterns
of microglia (from different brain regions) compared with periph-
eral monocytes and other tissue-resident macrophages (Butov-
sky et al., 2014). Rather, BM-derived brain macrophages
showed expression signatures similar to those of peripheral
myeloid cells. Even though the BM-derived cells are exposed
to the CNS environment and acquire microglia morphology,Figure 6. IL-1R1 Signaling Is Important for Microglia Repopulation
(A) NGS expression levels (±SEM) of Il1r1, Il1a, and Il1b in controls, CNS-derived MG, and BM macrophage
(B) qPCR validation of Il1r1, Il1a, and Il1b expression (±SEM).
(C) Immunohistochemistry of DTRMG d7 mice shows IL-1R1+ (green) and Iba1+ (red) cells with most promine
represent 40 mm.
(D) Immunohistochemistry of CNS vibratome slices of controls + IL-1Ra i.c.v., DTRMGmice + PBS i.c.v., and D
(red), GFAP (green), and DAPI (blue). Scale bars represent 40 mm.
(E) Quantification of microglia numbers (±SEM) in controls + IL-1Ra i.c.v., DTRMG mice + PBS i.c.v., and DTR
representative for the cortex.
Statistical significance (unpaired Student’s t test) is indicated as *p < 0.05, **p < 0.01, and ***p < 0.001. See
Immunity 43, 92–they retain their gene expression profile
that discloses their separate origin, at
least at the time points analyzed. Two
important genes, Il1r1 and Il1a, are highly
expressed in CNS-derived microglia, as
compared to BM macrophages. Neutrali-
zation of IL-1a by in vivo IL-1Ra treatment
impaired the repopulation event. How-ever, we did not completely block repopulation of microglia,
which could be due to the limited half-life of the IL-1Ra (Akash
et al., 2013) or the incomplete access to all brain regions upon
i.c.v. injection.
Strikingly, in 3-month-old IL-1R1MG mice, the microglia cell
numbers in the steady state are reduced throughout the CNS
and the cell morphology differs substantially in comparison to
WT mice. These findings suggest an essential role for IL-1
signaling, particularly in respect to proliferation, and in mainte-
nance of microglia. Further work is needed to unravel functional
differences between the different microglia populations.
Interestingly, DTRMG mice do not show any obvious patholog-
ical or behavioral phenotype after microglia ablation, although
detailed neurological tests were not performed. In a recent
report, Parkhurst et al. (2013) used a similar system to ablate mi-
croglia. Their mice presentedmultiple learning deficits after abla-
tion, but without any obvious CNS tissue alterations even during
microglia repopulation. In contrast, we could detect a striking
reactive astrogliosis and amassive increase in cytokine and che-
mokine production, indicative for a cytokine storm, as early as
3 days after microglia ablation. This obvious difference in tissue
response to microglia ablation could be due to distinct TAM in-
jection schemes resulting in differences in Cre induction. Wes.
nt expression of IL-1R1 in the clusters. Scale bars
TRMGmice + IL-1Ra i.c.v. were co-stained for Iba1
MG mice + IL-1Ra i.c.v. in 5 mice per group (n = 5)
Figures S6 and S7.
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used p12–p14 animals whereas Parkhurst et al. (2013) used p1–
p3 animals. Additionally, the age of the mice at ablation time
differed; we used p60 mice, whereas Parkhurst et al. (2013)
used p30 mice. Finally, Parkhurst et al. (2013) observed differ-
ences in p30 and p60, when analyzing dendritic spine elimina-
tion, which suggests that timing of DT injection is critical.
The source of this cytokine storm is likely the astrocytes, which
showed clear signs of continuous activation, evident by GFAP
expression upregulation. Indeed, a different microglia elimina-
tion protocol (Elmore et al., 2014) was also reported to result in
upregulation of GFAP on astrocytes, as early as day 7. This
observation is hardly surprising, because a slight disturbance
of CNS homeostasis is known to provoke astrocyte activation
and microglia ablation represents a massive disturbance of the
steady state.
Taken together, the use of Cx3cr1CreER mice enabled us to
specifically target microglia for DT-mediated cell ablation and
to study the consequences of microglia depletion on CNS ho-
meostasis. The observed fast repopulation of microglia after
ablation emphasizes the indispensable role of these cells to
maintain tissue integrity in the steady state. Moreover, our study
delivers yet another example for self-maintenance of tissue-resi-
dent macrophage populations that do not require the contribu-
tion of external progenitors. In addition, we found evidence for
the IL-1 signaling pathway being an important player within the
CNS, which is involved in local self-renewal and homeostasis
of microglia. Hence, our depletion system is a valuable tool for
studying the physiology of microglia in vivo.
EXPERIMENTAL PROCEDURES
Mice
Cx3cr1CreERmice (Yona et al., 2013) were bred to iDTRmice (Buch et al., 2005)
and R26-YFP reporter mice (Srinivas et al., 2001). Requests for IL-1R1 condi-
tional mice should be addressed to W.M. or A.W. All mice were on C57BL/6
background and housed in specific-pathogen-free conditions in the animal fa-
cility at the University of Mainz. All animal experiments were carried out in
accordance with the guidelines of the Central Animal Facility Institution
(ZVTE, University of Mainz).
Bone Marrow Transplantation
DTRMG mice were lethally irradiated with 9.5 Gray and reconstituted with 5 3
106 BM cells from R26-YFP mice (which were crossed to the deleter-Cre so
that all BM cells expressed YFP) or C57BL/6 Ly 5.1 donor animals.
Tamoxifen Treatment
Tamoxifen (TAM; Sigma) was suspended on 37C in olive oil for 60 min (MP
Biomedicals). 2 mg tamoxifen was administered subcutaneously (s.c.) twice
on postnatal days 12 and 14.
Microglia Depletion
For microglia depletion, mice were injected intraperitoneally (i.p.) with 500 ng
diphtheria toxin (DT; Merck Millipore) three times, with a 1-day interval be-
tween each injection.
BrdU Feeding
One day prior to and throughout depletion, mice were fed with 0.6 mg/ml BrdU
(Sigma) in the drinking water. The water was refreshed every third day and pro-
tected from light at all times.
Antibody Rreatment
a-CCR2 blocking antibodies (MC-21) and isotype control antibodies (MC-67)
were used over 5 days with one i.p. injection of 25 mg a day.104 Immunity 43, 92–106, July 21, 2015 ª2015 Elsevier Inc.CNS Isolation
Mice were anesthetized and perfused with NaCl and organs were excised out.
Brains were either fixed with 4% of PFA for histology, snap frozen in liquid
nitrogen for RNA preparation, or digested according to manufacturer’s guide-
lines supplied in the MACS tissue dissociation kit Papain (Miltenyi Biotec).
Tissue homogenate was loaded on a 30%:70% Percoll gradient for enrich-
ment of CNS infiltrates. The interphasic cellular ring was collected for further
investigation.
Histology
For vibratome sections, tissues were fixed overnight with 4% PFA,
embedded in 2% agarose, and cut sagittally at 40 mm. The sections were
stained with antibody to Iba1 (1:500, rabbit, Wako), GFP (1:5,000, rabbit,
abcam), GFAP (1:500, rabbit, DAKO), and BrdU (1:200, mouse, Roche).
Cy3 (1:200)-, Cy5 (1:200)-, and Alexa488 (1:200)-labeled secondary anti-
bodies were supplied by Jackson and Vector. Images were acquired with
a Lecia SP5 or SP8 confocal microscope or an Olympus ix81 fluorescence
microscope and further processed with ImageJ64 and Adobe Illustrator
CS4. For 3D reconstructions, 20 stacks were taken in a range of 20 mm in
a 633 magnification.
Quantification of Histology
The acquired images were counted blind by two independent people. 20
randomly depicted fields (203) per animal and at least three mice per group
were analyzed.
Flow Cytometry Staining, Acquisition, and Sorting
Single-cell suspensions for fluorescence-activated cell sorting (FACS) were
stained with surface antibodies purchased from eBioscience (CD45.2 FITC
#11-0454; CD11b PeCy7 #25-0112; CD86 APC #17-0862; MHCII Bio #13-
5321) or BD PharMingen (CD45.2 APC #558702; Ly6C V450 #560594) and
used according to the manufacturer’s protocol. Samples were acquired with
FACS Canto II and sorted with FACS Aria.
RNA Preparation
RNA was prepared from either whole brain tissue using the TRIzol reagent (In-
vitrogen), Lysing Matrix D tubes (MP Biomedicals), and a tissue ruptor (MP
FastPrep-24) or from FACS-sorted microglia with the RNeasy Plus Micro Kit
(QIAGEN) according to manufacturer’s guidelines.
Real-Time PCR
cDNA was synthesized out of 200–1,000 ng of RNA via SuperscriptII (Invitro-
gen). Quantitative real-time PCR was measured in an AB StepOnePlus Real
Time PCR ‘‘Thermocycler’’ (Life Technologies) with SYBR green (QIAGEN).
All primers were purchased from QIAGEN, as described on their homepage:
https://www.qiagen.com/us/products/catalog/assay-technologies/real-time-
pcr-and-rt-pcr-reagents/quantitect-primer-assays.
Next Generation Sequencing
Detailed procedures for NGS including data analysis are described in Supple-
mental Experimental Procedures.
Intracerebroventricular Injection of IL-1Ra
Mice were anesthetized with i.p. injections of Ketamin (40 mg/kg) and Xylazin
(5 mg/kg) and secured in a small animal stereotaxic frame (Kopf Instruments).
The injected side of the brain was cleaned and opened. A small hole was drilled
into the skull close to the injection site. A stainless-steel guide cannula (11mm,
24-gauge) was inserted into the third ventricle (2.5 mm post bregma, 3 mm
deep). 4 mg of IL-1Ra in a total volume of 2 ml was injected into the ventricle
over a period of 2 min. To reduce pain, the mice were injected with 4 mg/kg
of Rimadyl.
Data Analysis
Statistical analysis was performed with Prism Graph Pad (v.5.0b) and statisti-
cal environment R (v.3.0.2). The unpaired Student’s t test was used and all
bar graphs were represented as means ± SD and significance expressed as
follows: *p < 0.05; **p < 0.01; ***p < 0.001.
ACCESSION NUMBERS
The accession number for the data reported in this paper is GEO: GSE68376.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, five movies, and
Supplemental Experimental Procedures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.immuni.2015.06.012.
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